![]() |
市場調査レポート
商品コード
1519347
放射線腫瘍学市場レポート:タイプ、技術、用途、エンドユーザー、地域別、2024年~2032年Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
放射線腫瘍学市場レポート:タイプ、技術、用途、エンドユーザー、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
世界の放射線腫瘍学市場規模は2023年に81億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに145億米ドルに達し、2024年から2032年の間に6.5%の成長率(CAGR)を示すと予測しています。技術の進歩、がん罹患率の上昇、腫瘍放射線に関する意識の高まり、政府の取り組み、共同研究、新治療法の規制当局による承認、個別化医療の動向などが市場成長を促進する要因の一部です。
主な市場促進要因:放射線腫瘍学市場の成長を後押ししているのは、世界中で急増するがんの有病率などの要因です。効果的で正確な治療法に対する需要の高さが、画像誘導放射線治療や陽子線治療の開発を促し、市場成長をさらに刺激しています。もう一つの動向は、統計的にがんにかかりやすい老人人口の増加です。さらに、特に発展途上国における医療センター開発への投資や、政府・民間によるがん検診・予防イニシアチブの利用が、放射線腫瘍学のシェアを押し上げています。これに伴い、研究機関や企業は革新的な放射線療法の開発のために積極的に協力しており、これが市場の成長を後押ししています。
主要市場動向:放射線腫瘍学市場の主要動向の1つは、数回に分けて高線量の放射線を照射する低分割療法や超低分割療法へのシフトです。このアプローチは患者にとって便利であり、医療費の削減にもつながります。さらに、治療計画システムにおける人工知能(AI)や機械学習(ML)の利用が拡大しており、周囲の健康な組織へのダメージを抑えながら、従来のシステムよりも患部により正確に放射線を照射する、よりオーダーメイドの投与パターンが生み出され、市場の成長を加速させています。さらに、放射線治療と手術、化学療法、免疫療法などの他の治療を組み合わせたマルチモダリティ治療が引き続き恩恵をもたらし、治療成績がさらに向上しています。これとは別に、患者のQOL(生活の質)への影響を最小限に抑える治療スケジューリングの傾向が強まっていることも、放射線腫瘍学市場の成長を後押ししています。
地理的動向:現在、北米は世界の放射線腫瘍学市場の最先端を走っています。この地域の優位性には、高度なヘルスケアインフラ、高い医療費、著名な機器メーカーの存在など、いくつかの要因が寄与しています。この地域の市場地位の高さは、積極的に進められている調査や陽子線治療センターなどの新技術導入率の高さにも起因しています。さらに、欧州の市場拡大の原動力となっているのは、がん治療の質とアクセスの重要性を強調する厳格な医療政策と大規模な公衆衛生プログラムです。放射線腫瘍学市場の分析によると、アジア太平洋は新進気鋭の地域です。ヘルスケア支出は増加傾向にあり、がんに対する認識も高まっています。中国やインドなどでは、ヘルスケア施設の整備が進んでいます。
競合情勢:市場の競合情勢は、Accuray Incorporated、Becton Dickinson and Company、Canon Inc.、Elekta、日立製作所、Icad Inc.、Ion Beam Applications、Isoray Inc.、Mevion Medical Systems Inc.、Nordion(Canada)Inc.(Sotera Health)、P-Cure Ltd.、Varian Medical Systems Inc.(Siemens Healthineers AG)、ViewRayなど、放射線腫瘍学の主要企業の存在によって特徴付けられます。
課題と機会:放射線腫瘍学市場は、先進的な放射線治療システムに関連する高コストなどの課題に直面しており、これが豊かでない地域での市場浸透を制限する可能性があります。また、新技術の承認取得には時間とコストがかかるため、規制上のハードルも大きな課題となっています。さらに、新興市場では熟練した専門家が不足しており、これが先進治療の導入を妨げています。しかし、こうした課題はチャンスでもあります。例えば、費用対効果の高い放射線治療装置の開拓は、低所得国市場への浸透に役立ちます。また、がん医療従事者向けの教育イニシアティブやトレーニングプログラムは、有資格の専門家の不足を緩和することができます。
技術の進歩
世界の放射線腫瘍学市場に影響を与える主な要因のひとつは、絶えず進歩する技術です。強度変調放射線治療(IMRT)や画像誘導放射線治療(IGRT)の誕生を含む技術開発は、がん治療を再定義し、他の健康な体細胞へのダメージを最小限に抑えながら腫瘍をより正確に標的にすることを可能にしました。例えば、IMRTでは、照射する放射線量に強弱をつけています。この技術により腫瘍医は、周囲の健康な組織の破壊を最小限に抑えながら、腫瘍の複雑な形状に合わせて放射線ビームを適合させることができます。一方、IGRTは、CTスキャンやMRIなどの特殊な画像を利用して、各治療セッションの前に腫瘍の正確な位置を特定します。IGRTでは、腫瘍の高画質画像が得られるだけでなく、検査位置の確認や複数の機械化された放射線ビームによる治療が可能です。さらに、側方治療の進歩により陽子線治療が発明されました。この治療法は、従来のX線の代わりに高エネルギーの陽子線で放射線を照射するもので、副作用を最小限に抑えながら優れた線量集中を可能にします。たとえば2024年には、核兵器関連の科学機関を中心とする中国の研究グループによって、フラッシュと呼ばれる強力な照射システムが設計されました。超高エネルギーの放射線を照射できるこのシステムは、従来の放射線治療を一変させる可能性を秘めています。
がん罹患率の上昇
世界の放射線腫瘍学市場は、主に発展途上諸国を中心とした世界全体のがん発生率の増加によって煽られています。世界保健機関(WHO)による世界のがんの発生に関する最新の報告書によると、インドでは2022年に1,410万人以上が新たにがんに罹患し、910万人以上ががんに関連して死亡しました。乳がんは、世界の疾病発生の指標として最も多く確認されており、新規疾病の10分の1以上を占めています。がんの有病率は年齢が上がるにつれて上昇します。さらに、長年知られていた可能性の変化や長年の環境の存在も、さらなる成長要因です。放射線腫瘍学の需要は、がん患者の増加によっても後押しされ、国際的に最も一般的な死因のひとつになると予測されています。
意識の高まりと政府の取り組み
がんの早期診断と早期治療の重要性に関する知識の高まり、またがん患者が質の高い治療を受けられるようにするための公共部門の積極的な取り組みと資源の配分が、放射線腫瘍学の世界の成長を促進しています。さまざまな非政府組織(NGO)や国際機関により、がんに対する患者の認識を高め、放射線治療サービスの必要性を高めるための啓発プログラムやキャンペーンが実施されています。政府の医療機関もまた、放射線サービスへのアクセスを強化し、がんの負担を軽減するために、がん対策、施設開発、支払い制度に投資しており、これが放射線腫瘍学市場の展望をさらに後押ししています。
The global radiation oncology market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032. Technological advancements, rising cancer incidence, increasing awareness regarding oncology radiation, government initiatives, and collaborations, regulatory approvals for new therapies, and the trend towards personalized medicine are some of the factors fostering the market growth.
Major Market Drivers: The radiation oncology market growth is fueled by the factors, including the surging prevalence of cancer across the globe. The high demand for effective and accurate treatment methods prompts the development of image-guided radiation therapy and proton therapy, which is further stimulating the market growth. Another trend is also the rise in the number of geriatric population that is statistically more prone to cancer. In addition, investments in the development of medical centers, especially in developing countries, and availability of government and private cancer screening and prevention initiatives are driving the radiation oncology market share. In line with this, research institutions and companies are actively joining forces for the development of innovative radiation therapies, which is favoring the market growth.
Key Market Trends: One of the key radiation oncology market trends is the shift toward hypofractionated and ultra-hypofractionated therapies, in which higher doses of radiation are given over few sessions. This approach is convenient for patients and reduces medical expenditures. Moreover, the use of artificial intelligence (AI) and machine learning (ML) in treatment planning systems is growing, producing more tailored administration patterns which deliver radiation more precisely to the affected location than traditional systems while reducing damage to surrounding healthy tissue, which is accelerating the market growth. Furthermore, multimodality treatments continue to provide a boon, combining radiation therapy with other treatments like surgery, chemotherapy, and immunotherapy, which further improves therapeutic outcomes. Apart from this, the growing trend towards therapeutic scheduling that minimizes the impact of the therapy on the patient's quality of life is driving the radiation oncology market growth.
Geographical Trends: At present, North America is at the forefront of the world's radiation oncology market. Several factors contribute to this region's dominance, including the advanced healthcare infrastructure, high healthcare spending, and the presence of prominent device manufacturers. The region's strong market position also stems from research being pursued aggressively and high rates of new technology adoption, such as proton therapy centers. Moreover, Europe's market expansion is driven by stringent healthcare policies and large-scale public health programs that stress the importance of cancer treatment quality and accessibility. As per the radiation oncology market analysis, the Asia-Pacific is an up-and-coming region. Healthcare spending is on the rise, and cancer awareness is growing. The healthcare facilities are becoming more advanced in countries such as China and India.
Competitive Landscape: The competitive landscape of the market is characterized by the presence of key radiation oncology companies, such as Accuray Incorporated, Becton Dickinson and Company, Canon Inc., Elekta, Hitachi Ltd., Icad Inc., Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion (Canada) Inc. (Sotera Health), P-Cure Ltd., Varian Medical Systems Inc. (Siemens Healthineers AG), ViewRay, etc.
Challenges and Opportunities: The radiation oncology market faces challenges such as high costs associated with advanced radiation therapy systems, which can limit market penetration in less affluent regions. Regulatory hurdles also pose significant challenges, as gaining approval for new technologies can be time-consuming and costly. Moreover, there is a shortage of skilled professionals in emerging markets, which hampers the adoption of advanced therapies. However, these challenges also present opportunities. For example, the development of cost-effective radiation therapy machines can help penetrate low-income markets. Educational initiatives and training programs for oncology care providers can alleviate the shortage of qualified professionals.
Technological Advancements
One of the major factors influencing the global radiation oncology market is the continually advancing technology. Technological development, including the creation of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), have redefined the treatment of cancer, enabling more accurate targeting of tumors with minimal damage to other healthy body cells. For example, IMRT employs varied intensities in the radiation doses it administers. This technology enables oncologists to conform the radiation beams according to the complicated shape of the tumor with minimal destruction of surrounding healthy tissues. IGRT, on the other hand, utilizes specialized imagining such as CT scans or MRIs to identify the tumor's exact location before each treatment session. In addition to producing high quality images of the tumor, IGRT offers test position verification and treatment carrying out several mechanized radiation beams. Further, lateral therapy advancements have resulted in the invention of proton therapy. This therapy administers radiation with high-energy protons instead of traditional x-rays, allowing superior dose concentration with minimal side effects. For instance, in 2024, a powerful irradiation system called the Flash was designed by a Chinese research group mainly from nuclear weapons related scientific institutions. The system is capable of administering ultra-high energy radiation and has the potential to transform conventional radiotherapy.
Rising Incidence of Cancer
The global radiation oncology market is primarily fueled by an increase in cancer occurrence across the world, mainly in developing countries. According to the most recent report on the global occurrence of the disease by the World Health Organization (WHO), there were over 14.1 lakh new cancer instances and more than 9.1 lakh cancer-related deaths in India in 2022. Breast cancer was the most frequently identified measure of global occurrence of the disease, accounting for more than one-tenth of all new illnesses. The prevalence of cancer rises as people age; moreover, a change in long-known chances and the presence of longstanding environmental are additional growth factors. The radiation oncology demand is also boosted by the growing number of cancer patients, which is predicted to be one of the most common causes of death internationally.
Increasing Awareness and Government Initiatives
Rising knowledge about the importance of early cancer diagnosis and treatment, as well as public sector proactiveness and allocation of resources to ensure that cancer patients receive high-quality care, are driving the growth of radiation oncology globally. Several public awareness programs and campaigns are being implemented by various non-governmental organizations (NGOs) and international organizations to boost patient awareness of cancer and the rising need for radiation therapy services. Government health agencies are also investing in cancer control, facilities development, and payment schemes to enhance access to radiation services and reduce the cancer burden, which is further driving the radiation oncology market outlook.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type, technology, application, and end user.
External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Proton Therapy
Internal Beam Radiation Therapy
Brachytherapy
Systemic Beam Radiation Therapy
Others
External beam radiation therapy (EBRT) accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (linear accelerators, compact advanced radiotherapy systems, proton therapy) and internal beam radiation therapy (brachytherapy, systemic beam radiation therapy, and others). According to the report, external beam radiation therapy (EBRT) represented the largest segment.
Image-Guided Radiotherapy (IGRT)
Intensity Modulated Radiotherapy (IMRT)
Stereotactic Technology
Proton Beam Therapy
3D Conformal Radiotherapy (3D CRT)
Volumetric Modulated Arc Therapy (VMAT)
Brachytherapy
The report has provided a detailed breakup and analysis of the market based on the technology. This includes image-guided radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), stereotactic technology, proton beam therapy, 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), and brachytherapy.
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Colorectal Cancer
Gynecological Cancer
Cervical Cancer
Penile Cancer
Others
The report has provided a detailed breakup and analysis of the market based on the application. This includes prostate cancer, breast cancer, lung cancer, head and neck cancer, colorectal cancer, gynecological cancer, cervical cancer, penile cancer, and others.
Hospitals
Cancer Research Institutes
Ambulatory and Radiotherapy Centers
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest radiation oncology market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.